Validation of pre-operative 3.0 Tesla H1-MR spectroscopy for assessment of hepatic steatosis as a risk factor for post-operative outcome after hepatectomy

Validation of pre-operative 3.0 Tesla H1-MR spectroscopy for assessment of hepatic steatosis as a risk factor for post-operative outcome after hepatectomy - Validation of H1-MR spectroscopy for assessment of hepatic steatosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30877

Enrollment

Registered

2007-07-12

Start date

2007-05-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver Liver steatosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients over 18 years of age Patients who require a liver resection for: - hepatocellular carcinoma - colorectal metastasis - benign tumors

Exclusion criteria

Exclusion criteria: Patients under 18 years of age Patients not suitable for surgery in case of co-morbidity Patients who are pregnant Patients who require an acute liver resection Patients who are claustrophobic (MRI scanner) Patients who have magnetic or radiofrequency sensitive implants (MRI scanner) Patients with extreme obesity (MRI scanner)

Design outcomes

Primary

Measure	Time frame
Valdation and quantification of hepatic steatosis with 3.0 Tesla 1H*MRS and correlation with clinical parameters and histological and biochemical analysis of liver biopsies	—

Secondary

Measure	Time frame
influence of hepatic steatosis on postoperative morbidity and mortality	—

Countries

Netherlands

Outcome results